MYCN and neuroblastoma: Our analysis of GALNT13 mRNA transcripts in various NB cell lines, as well as in favorable and high-risk neuroblastic tumors, showed that GALNT13 is highly expressed in more aggressive neuroblasts but is not correlated with MYCN amplification and/or expression.